Inhibiting pathogenic bacteria and stopping the proliferation of cancer cells Using MCF-7 fenugreek seed extract for breast Alcoholic
IQ8372BUndetermined Publication Date: 2024-12-15DR LINA ABBAS NASSER
0 Cites 0 Cited by
Patent Information
- Application Number
- IQ2019512
- Authority / Receiving Office
- IQ · IQ
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2019-07-22
- Publication Date
- 2024-12-15
- Estimated Expiration
- 2039-07-22
Abstract
The current study was conducted to investigate the possibility Using fenugreek seed extract against cancer cells For humans, two MCF-7 breast lines were also used. For cancer, specifically liver cancer cells And also the Vero HCAM cell line Natural (non-cancerous) as a comparison using Colorimetric. The MTT extract showed an assay Fenugreek seeds exhibit clear activity against alcohol. Staphylococcus and Pseudomonas aeruginosa The alcoholic extract of fenugreek aureus seeds showed Inhibiting and stopping the growth of breast cancer cells without taking Cell death (apoptosis or necrosis) pathway Programmed cell death (or necrosis) occurred in a dose-dependent manner after 72 hours of incubation, while the HCAM extract showed no anticancer effect on cell lines. Fenugreek seed extract showed Vero activity and Antibacterial activity against pathogenic bacteria was tested at various levels. The current MCF-7 study demonstrated the effect of fenugreek seed extract on tissues. HCAM and no effect was observed on the cell line To our knowledge, no study has demonstrated inhibition of human breast cancer cells without the occurrence of apoptosis or necrosis. This finding focuses on the potential benefit of fenugreek extract for the treatment of breast cancer.
Need to check novelty before this filing date? Find Prior Art